Evidence map›Paper›PMID 42742755›Full record

Trial reportEuropean journal of nutrition2026

Effects of 12 weeks of resistance and concurrent training with graded protein intakes on lipid profile, kidney and liver biomarkers in middle-aged to older women.

Reza Bagheri, Hamid Ghobadi, Mehdi Kargarfard, Katsuhiko Suzuki

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reza BagheriDepartment of Exercise Physiology, University of Isfahan, Isfahan, Iran.
Hamid GhobadiDepartment of Exercise Physiology, Ferdowsi University of Mashhad, Mashhad, Iran.
Mehdi KargarfardDepartment of Exercise Physiology, University of Isfahan, Isfahan, Iran. m.kargarfard@spr.ui.ac.ir.
Katsuhiko SuzukiFaculty of Sport Sciences, Waseda University, Shinjuku, Japan. katsu.suzu@waseda.jp.

Funding

Iran National Science Foundation (INSF) 4036777
6 · The paper itself

Abstract

purposeTo examine secondary lipid, kidney-related, and liver-enzyme responses to three protein intakes during resistance training (RT) alone or the same RT plus cycling (CT) in middle-aged to older women.

methodsIn this randomized 2×3 factorial trial, 108 women aged 40-77 years were assigned to RT or CT and 0.8, 1.6, or 2.2 g kg

resultsTriglycerides, total cholesterol, LDL-C, and apolipoprotein B decreased and HDL-C increased in all conditions. Lipid changes differed by protein condition, and several were more favorable with CT; however, CT comprised RT plus additional cycling and greater exercise exposure. Urea, blood urea nitrogen, creatinine, the blood urea nitrogen-to-creatinine ratio, and cystatin C increased, whereas three eGFR estimates decreased. Responses differed mainly between 0.8 and the two higher protein conditions, with little evidence of differences between 1.6 and 2.2 g kg

conclusionsThe dietary and exercise interventions modified lipid and clinical-chemistry responses. Because energy and food composition were not fully matched and CT added cycling to RT, the findings do not isolate protein dose or exercise modality. Changes in eGFR estimates and liver enzymes do not establish organ injury or long-term safety.

Indexed as

Dietary ProteinsKidneyLipidsLiverResistance TrainingAdultAgedBiomarkersBlood Urea NitrogenCholesterol, HDLCreatinineFemaleHumansMiddle AgedTriglyceridesBiomarkersCholesterol, HDLCreatinineDietary ProteinsLipidsTriglyceridesDyslipidemiaMetabolic dysfunctionMetabolic functionNutrition

Identifiers

PMID42742755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.